NAYA Biosciences Inc. (NAYA)
NASDAQ: NAYA
· Real-Time Price · USD
2.20
0.17 (8.37%)
At close: Apr 25, 2025, 3:59 PM
NAYA Biosciences Cash Flow Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -17.4M | -3.62M | -1.63M | -2.25M | -1.6M | -1.99M | -1.25M | -2.24M | -2.55M | -2.77M | -2.55M | -2.8M | -2.77M | -141.53K | -2.24M | -1.82M | -2.45M |
Depreciation & Amortization | 234.46K | 231.81K | 230.5K | 230.34K | 226.96K | 141.6K | 20.5K | 19.7K | 76.95K | 77.55K | 77.1K | 79.22K | 72.45K | 79.36K | 31.58K | 31.56K | 8.56K |
Stock-Based Compensation | 70.66K | 169.37K | 106.33K | 1.1M | 213.84K | 179.53K | 265.47K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | -278.83K | 824.56K | 134.76K | -308.94K | -148.71K | 524.67K | -677.45K | 93.88K | 83.84K | 383.85K | 42.55K | 114.02K | -189.75K | -3.01M | -54.07K | -216.72K | -393.34K |
Other Non-Cash Items | 14.76M | 611.75K | 259.02K | 268.62K | 610.05K | 434.1K | 364.32K | 532.33K | 773.35K | 632.06K | 572.09K | 715.88K | 809.82K | 1.63M | 487.42K | 538.68K | 1.43M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 810.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -1.21M | 1.99M | 394.01K | -809.55K | 285.11K | 524.67K | -649.17K | 44.08K | 552.12K | 1.05M | 252.17K | 133.65K | -186.07K | -3.07M | 114.11K | 73.17K | -719.31K |
Operating Cash Flow | -3.55M | -617.38K | -640.81K | -1.46M | -260.56K | -714.88K | -1.25M | -1.64M | -1.15M | -1M | -1.65M | -1.87M | -2.08M | -1.51M | -1.61M | -1.17M | -1.74M |
Capital Expenditures | -14.65K | -78.87K | n/a | -55.13K | -49.7K | -75K | -108.22K | -261.5K | n/a | 135.00 | -2.59K | -2.68K | -5.65K | 328.54K | -744.25K | 3.00 | 4.00 |
Cash Acquisitions | n/a | 472.01K | n/a | n/a | n/a | 108.29K | -2.15M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -8.45K | 8.45K | n/a | -1.61K | -75.33K | -1.45M | -252.88K | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | 50K | 25.59K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 200K | 680K | -600K | -280K |
Investing Cash Flow | -14.65K | 393.13K | n/a | -5.13K | -24.11K | 33.29K | -2.26M | -261.5K | -8.45K | 8.58K | -3.01K | -4.9K | -81.89K | -917.84K | -320.29K | -606.4K | -308.98K |
Debt Repayment | -1.09M | 494.05K | 31.96K | -143.55K | 27.37K | -141.53K | 1.45M | -190.15K | 544K | 800K | n/a | n/a | n/a | -250K | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 88.00 | n/a | n/a | 900.61K | n/a | 23.05K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Financial Cash Flow | 3.66M | 494.05K | 169.46K | 1.93M | 527.37K | -141.53K | 4.45M | -169.86K | 3.26M | 800K | -25.2K | n/a | 315K | 3.4M | n/a | n/a | 369.84K |
Net Cash Flow | 99.01K | 269.81K | -471.34K | 467.81K | 242.7K | -823.12K | 943.06K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Free Cash Flow | -3.56M | -696.25K | -640.81K | -1.51M | -310.25K | -789.88K | -1.36M | -1.91M | -1.15M | -1M | -1.65M | -1.88M | -2.08M | -1.18M | -2.35M | -1.17M | -1.74M |